Centivax

South San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of a broad-spectrum vaccine designed to treat and eradicate rapidly mutating pathogens. Centivax is based in South San Francisco, CA and was founded in 2019. Its last reported valuation was $95 million in Jul 2025. It has raised $92 million.

Last reported valuation
$95.0M
Oct 2026
Priced at
—
Total raised
$92.0M
Last round
—

Who backs Centivax?

14 investors
InvestorType
NFXVenture capital
Amplify PartnersVenture capital
Future Ventures (San Francisco)Venture capital
Patrick CollisonAngel
BOLD Capital PartnersVenture capital
Coalition for Epidemic Preparedness InnovationsOther
Global Health Investment CorporationOther
Abbhi CapitalPE / buyout
Base4 CapitalHedge fund
John Collison—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Centivax investors

14 investors are on record for Centivax, including NFX, Amplify Partners, Future Ventures (San Francisco) and Patrick Collison. By type, the record holds 4 venture capital firms and 1 hedge fund.

Free account
More of Centivax with a free account
  • ·The complete investor list: 14 names
  • ·Watch Centivax: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Centivax. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View